% This is the RIPE Database query service.
% The objects are in RPSL format.
%
% The RIPE Database is subject to Terms and Conditions.
% See https://apps.db.ripe.net/docs/HTML-Terms-And-Conditions

% Information related to '94.143.227.0 - 94.143.227.255'

% Abuse contact for '94.143.227.0 - 94.143.227.255' is '[email protected]'

inetnum: 94.143.227.0 - 94.143.227.255
netname: DK-XELLIA-20220125
country: DK
org: ORG-XPA1-RIPE
admin-c: XA446-RIPE
tech-c: XA446-RIPE
status: ALLOCATED PA
mnt-by: XELLIA-MNT
mnt-by: RIPE-NCC-HM-MNT
created: 2022-01-25T12:47:25Z
last-modified: 2022-01-25T12:47:25Z
source: RIPE

organisation: ORG-XPA1-RIPE
org-name: Xellia Pharmaceuticals ApS
country: DK
org-type: LIR
address: Dalslandsgade 11
address: 2300
address: Koebenhavn S
address: DENMARK
phone: +4532645500
e-mail: [email protected]
admin-c: XA446-RIPE
tech-c: XA446-RIPE
abuse-c: AR66700-RIPE
mnt-ref: XELLIA-MNT
mnt-by: RIPE-NCC-HM-MNT
mnt-by: XELLIA-MNT
created: 2021-11-26T07:03:45Z
last-modified: 2021-11-26T07:03:46Z
source: RIPE

role: XIO1-RIPE
address: DENMARK
address: Koebenhavn S
address: 2300
address: Dalslandsgade 11
phone: +4532645500
e-mail: [email protected]
nic-hdl: XA446-RIPE
mnt-by: XELLIA-MNT
created: 2021-11-26T07:03:45Z
last-modified: 2021-11-26T07:03:45Z
source: RIPE